DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
CHLOROTHIAZIDE; METHYLDOPA
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLOROTHIAZIDE; METHYLDOPA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
XAMOTEROL FUMARATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
XAMOTEROL FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
N87007N668
Molecule Type:
Small molecule
Molecular Formula:
C36H54N6O14
Molecular Weight:
794.86
AlogP:
-0.24
PSA:
103.29
HBD:
4.0
HBA:
#RotB:
8.0
Source:
LACTOBACILLUS CASEI
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
LACTOBACILLUS CASEI
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
QUINUPRISTIN; DALFOPRISTIN
4
Combination
Approved
CANCER
INJECTION
Unknown
Unknown
QUINUPRISTIN; DALFOPRISTIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
QUINUPRISTIN/DALFOPRISTIN
4
Unknown
Approved
Unknown
Unknown
Osteomyelitis; Gram-Positive Bacterial Infections; Bacterial Infections
Bacterial 70S ribosome inhibitor
QUINUPRISTIN/DALFOPRISTIN
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
C87H117N13O19S2
Molecular Weight:
1713.1
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAMIVUDINE; ZIDOVUDINE; ABACAVIR
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
LAMIVUDINE; ZIDOVUDINE; ABACAVIR
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACETARSONE
4
Small molecule
Approved
Unknown
Unknown
Leishmaniasis; Trypanosomiasis
Unknown
ACETARSONE
×
Maximum Phase:
4
First Approval:
None
UNII:
806529YU1N
Molecule Type:
Small molecule
Molecular Formula:
C8H10AsNO5
Molecular Weight:
275.09
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZARIBINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Uridine 5'-monophosphate synthase inhibitor
AZARIBINE
×
Maximum Phase:
4
First Approval:
None
UNII:
K1U80DO9EB
Molecule Type:
Small molecule
Molecular Formula:
C14H17N3O9
Molecular Weight:
371.3
AlogP:
-1.74
PSA:
155.88
HBD:
1.0
HBA:
#RotB:
5.0
Source:
PARECOXIB
4
Small molecule
Approved
Unknown
Unknown
Shoulder Pain; Fractures, Bone; Pain; Renal Colic; Rheumatic Diseases
Cyclooxygenase-2 inhibitor
PARECOXIB
×
Maximum Phase:
4
First Approval:
None
UNII:
9TUW81Y3CE
Molecule Type:
Small molecule
Molecular Formula:
C19H18N2O4S
Molecular Weight:
370.43
AlogP:
3.53
PSA:
89.27
HBD:
1.0
HBA:
#RotB:
5.0
Source:
DAPAGLIFLOZIN; SAXAGLIPTIN
4
Combination
Approved
Unknown
Unknown
Unknown
Unknown
DAPAGLIFLOZIN; SAXAGLIPTIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PROPICILLIN
4
Small molecule
Approved
Unknown
Unknown
Bacterial Infections
Unknown
PROPICILLIN
×
Maximum Phase:
4
First Approval:
None
UNII:
8X1R260V33
Molecule Type:
Small molecule
Molecular Formula:
C18H22N2O5S
Molecular Weight:
378.45
AlogP:
1.48
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
6.0
Source:
METABROMSALAN
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
METABROMSALAN
×
Maximum Phase:
4
First Approval:
None
UNII:
8Q21Y09R21
Molecule Type:
Small molecule
Molecular Formula:
C13H9Br2NO2
Molecular Weight:
371.03
AlogP:
4.17
PSA:
49.33
HBD:
2.0
HBA:
#RotB:
2.0
Source:
COLESTILAN CHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic
Phosphate sequestering agent
COLESTILAN CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
VSI302RYSR
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLUFENAMIC ACID
4
Small molecule
Approved
Unknown
Unknown
Rheumatic Diseases
Unknown
FLUFENAMIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
60GCX7Y6BH
Molecule Type:
Small molecule
Molecular Formula:
C14H10F3NO2
Molecular Weight:
281.23
AlogP:
4.15
PSA:
49.33
HBD:
2.0
HBA:
#RotB:
3.0
Source:
FENOVERINE
4
Small molecule
Approved
Unknown
Unknown
Digestive System Diseases
Unknown
FENOVERINE
×
Maximum Phase:
4
First Approval:
None
UNII:
N274ZQ6PZJ
Molecule Type:
Small molecule
Molecular Formula:
C26H25N3O3S
Molecular Weight:
459.57
AlogP:
4.36
PSA:
45.25
HBD:
0.0
HBA:
#RotB:
4.0
Source:
EPOETIN ZETA
4
Protein
Approved
Unknown
Unknown
Diabetic Foot
Erythropoietin receptor agonist
EPOETIN ZETA
×
Maximum Phase:
4
First Approval:
None
UNII:
64FS3BFH5W
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASPIRIN; OMEPRAZOLE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
ASPIRIN; OMEPRAZOLE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ABACAVIR;LAMIVUDINE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ABACAVIR;LAMIVUDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MESTEROLONE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
MESTEROLONE
×
Maximum Phase:
4
First Approval:
None
UNII:
0SRQ75X9I9
Molecule Type:
Small molecule
Molecular Formula:
C20H32O2
Molecular Weight:
304.47
AlogP:
4.21
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
0.0
Source:
DEXFENFLURAMINE
4
Small molecule
Approved
Unknown
Unknown
Obesity
Unknown
DEXFENFLURAMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
E35R3G56OV
Molecule Type:
Small molecule
Molecular Formula:
C12H16F3N
Molecular Weight:
231.26
AlogP:
3.25
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ARTENIMOL
4
Small molecule
Approved
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Lupus Erythematosus, Systemic; Fever; Malaria, Falciparum; Malaria, Vivax; Malaria
Unknown
ARTENIMOL
×
Maximum Phase:
4
First Approval:
None
UNII:
6A9O50735X
Molecule Type:
Small molecule
Molecular Formula:
C15H24O5
Molecular Weight:
284.35
AlogP:
2.19
PSA:
57.15
HBD:
1.0
HBA:
#RotB:
0.0
Source:
SIMETICONE
4
Unknown
Approved
Unknown
Unknown
Constipation
Anti-gas, surfactant
SIMETICONE
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BLONANSERIN
4
Small molecule
Approved
Unknown
Unknown
Schizophrenia
Dopamine D2 receptor antagonist
BLONANSERIN
×
Maximum Phase:
4
First Approval:
None
UNII:
AQ316B4F8C
Molecule Type:
Small molecule
Molecular Formula:
C23H30FN3
Molecular Weight:
367.51
AlogP:
4.69
PSA:
19.37
HBD:
0.0
HBA:
#RotB:
3.0
Source:
TECHNETIUM TC 99M MEDRONATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
TECHNETIUM TC 99M MEDRONATE
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
CH6O6P2Tc
Molecular Weight:
274.91
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
LIDOCAINE HYDROCHLORIDE; OXYTETRACYCLINE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
LIDOCAINE HYDROCHLORIDE; OXYTETRACYCLINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CEFADROXIL/CEFADROXIL HEMIHYDRATE
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
CEFADROXIL/CEFADROXIL HEMIHYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROCORTISONE ACETATE; OXYTETRACYCLINE HYDROCHLORIDE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
HYDROCORTISONE ACETATE; OXYTETRACYCLINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TECHNETIUM TC 99M (PYRO- AND TRIMETA-) PHOSPHATES
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TECHNETIUM TC 99M (PYRO- AND TRIMETA-) PHOSPHATES
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TECHNETIUM MEDRONATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
TECHNETIUM MEDRONATE
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
CH6O6P2Tc
Molecular Weight:
274.0
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ADALIMUMAB-BWWD
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ADALIMUMAB-BWWD
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LOFEPRAMINE HYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
LOFEPRAMINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Z24K96F991
Molecule Type:
Small molecule
Molecular Formula:
C26H28Cl2N2O
Molecular Weight:
455.43
AlogP:
5.78
PSA:
23.55
HBD:
0.0
HBA:
#RotB:
7.0
Source:
PADIMATE O
4
Small molecule
Approved
Unknown
Unknown
Melanosis
Unknown
PADIMATE O
×
Maximum Phase:
4
First Approval:
None
UNII:
Z11006CMUZ
Molecule Type:
Small molecule
Molecular Formula:
C17H27NO2
Molecular Weight:
277.41
AlogP:
4.13
PSA:
29.54
HBD:
0.0
HBA:
#RotB:
8.0
Source:
1
2
…
251
252
253
254
255
256
257
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA